Levetiracetam Sun

Levetiracetam, the active ingredient in Levetiracetam Sun, is an anticonvulsant presented as an intravenous solution for intravenous use. It is employed to treat partial seizures, generalized tonic‑clonic seizures, myoclonic seizures and other epilepsy types in both adult and pediatric patients.

GNH USA supplies Levetiracetam Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, adhering to stringent quality standards and providing reliable global distribution for clinical use.

Levetiracetam is an anticonvulsant indicated for several seizure types within the epilepsy disease spectrum.

Partial seizures: Decreases the frequency of focal seizure episodes in patients with epilepsy. Generalized tonic‑clonic seizures: Reduces the occurrence of bilateral convulsive seizures. Myoclonic seizures: Helps control rapid, brief muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Somnolence or fatigue - Headache - Irritability or mood swings - Nausea or abdominal discomfort - Nasal congestion

Serious or Rare Side Effects: - Severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome - Blood dyscrasias including agranulocytosis or thrombocytopenia - Suicidal thoughts or major depressive episodes - Respiratory depression when combined with other CNS depressants

When using Levetiracetam, clinicians should observe several precautionary measures to ensure safe therapy.

Renal impairment: Adjust dosage based on creatinine clearance. Pregnancy: Category B; prescribe only when benefit outweighs potential risk. Mood changes: Monitor for depression, irritability, or suicidal ideation. Discontinuation: Do not stop abruptly; taper under medical supervision. Drug interactions: Review concomitant antiepileptic drugs for possible level alterations. Store at ambient temperature: Keep in original container, protect from moisture and light.

Levetiracetam can interact with other medicines, affecting its plasma concentration or enhancing central nervous system effects.

Major Interactions (Avoid): - Carbamazepine: Increases metabolism, reducing levetiracetam levels. - Phenobarbital: Induces hepatic enzymes, lowering drug exposure. - Phenytoin: Accelerates clearance, potentially compromising efficacy.

Moderate Interactions (Monitor Closely): - Valproic acid: May increase levetiracetam concentrations. - Other CNS depressants (e.g., benzodiazepines): Additive sedation risk. - Alcohol: Enhances central nervous system depression and dizziness.